CN109331118A - It is a kind of to treat the Chinese medicine that haemocyte declines after tumor chemoradiotherapy - Google Patents

It is a kind of to treat the Chinese medicine that haemocyte declines after tumor chemoradiotherapy Download PDF

Info

Publication number
CN109331118A
CN109331118A CN201811484210.7A CN201811484210A CN109331118A CN 109331118 A CN109331118 A CN 109331118A CN 201811484210 A CN201811484210 A CN 201811484210A CN 109331118 A CN109331118 A CN 109331118A
Authority
CN
China
Prior art keywords
leaf
haemocyte
declines
root
turtle shell
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201811484210.7A
Other languages
Chinese (zh)
Inventor
吴�琳
叶峥嵘
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201811484210.7A priority Critical patent/CN109331118A/en
Publication of CN109331118A publication Critical patent/CN109331118A/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/07—Basidiomycota, e.g. Cryptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/58—Reptiles
    • A61K35/586—Turtles; Tortoises, e.g. terrapins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/07—Basidiomycota, e.g. Cryptococcus
    • A61K36/076—Poria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/481—Astragalus (milkvetch)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/61—Myrtaceae (Myrtle family), e.g. teatree or eucalyptus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/80—Scrophulariaceae (Figwort family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
    • A61K36/815—Lycium (desert-thorn)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/898—Orchidaceae (Orchid family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The Chinese medicine that haemocyte declines after tumor chemoradiotherapy is treated the invention discloses a kind of, is made of dried thin mushroom, fern fiber crops, turtle shell, thatch screwpine fruit, PORIA ALBA, ford nervilia leaf, lycium ruthenicum, henry woodbetony root, Radix Astragali, Rabdosia amethystoides, gurgeon stopper, eclipta and hairyflower actinidia root and leaf.Compared with prior art, haemocyte declines after the present invention can effectively treat tumor chemoradiotherapy, to effectively mitigate patient suffering, improves the life quality of patient, and have Small side effects and value easy to promote and utilize.

Description

It is a kind of to treat the Chinese medicine that haemocyte declines after tumor chemoradiotherapy
Technical field
The present invention relates to tumour medicine technical field more particularly to a kind of treat after tumor chemoradiotherapy in haemocyte decline Medicine.
Background technique
Chemicotherapy is the abbreviation of radiation and chemotherapy, and radiotherapy is to kill using radioactive ray to cell, chemotherapy application Chemicals destroy cell.In recent years, chemicotherapy has become that malignant tumour is common and important treatment means.Due to putting Chemotherapy can destroy other cells of human body while killing tumour cell and tumour growth is inhibited to breed, and especially be proliferated Rapid cell, therefore usually will cause the reduction of the haemocytes such as tumor patient leucocyte, red blood cell and blood platelet in the application, Drastically influence the life health and quality of life of patient.Treat what haemocyte after tumor chemoradiotherapy declined therefore, it is necessary to a kind of Drug.
Summary of the invention
The object of the invention is that providing a kind of treat after tumor chemoradiotherapy under haemocyte to solve the above-mentioned problems The Chinese medicine of drop.
The present invention through the following technical solutions to achieve the above objectives:
The present invention by dried thin mushroom, fern fiber crops, turtle shell, thatch screwpine fruit, PORIA ALBA, ford nervilia leaf, lycium ruthenicum, henry woodbetony root, Radix Astragali, Rabdosia amethystoides, Gurgeon stopper, eclipta and hairyflower actinidia root and leaf are made.
Preferably, by weight, contain the dried thin mushroom 15%, the fern fiber crops 5%, the turtle shell 20%, the thatch screwpine fruit for every part 4%, the PORIA ALBA 4%, the ford nervilia leaf 5%, the lycium ruthenicum 5%, the henry woodbetony root 13%, the Radix Astragali 6%, the Rabdosia amethystoides 6%, the gurgeon stopper 7%, the eclipta 5%, the hairyflower actinidia root and leaf 5%.
Preparation method of the present invention the following steps are included:
(1) net turtle shell to be scalded with sand faint yellow to surface, taking-up weeds out sand, puts into vinegar liquid quench it while hot, pull out, and it is dry, Vinegar turtle shell is made；
(2) by vinegar turtle shell, dried thin mushroom, fern fiber crops, thatch screwpine fruit, PORIA ALBA, ford nervilia leaf, lycium ruthenicum, henry woodbetony root, Radix Astragali, Rabdosia amethystoides, red Nanmu, eclipta and hairyflower actinidia root and leaf weigh in proportion, are pulverized and mixed after carrying out ultraviolet sterilization, and investment blender is sufficiently mixed uniformly, Obtain premix；
(3) tabletting on tablet press machine by premix is dried 6-8 hours at 50-55 DEG C,
(4) medicinal powder after drying is put into tablet press machine carry out it is tabletted to obtain the final product.
The beneficial effects of the present invention are:
The present invention be it is a kind of treat the Chinese medicine that haemocyte declines after tumor chemoradiotherapy, compared with prior art, the present invention can have Haemocyte declines after the treatment tumor chemoradiotherapy of effect, to effectively mitigate patient suffering, inhibits tumour growth, and use Chinese medicine Preparation, Small side effects have the value of popularization and application.
Specific embodiment
The invention will be further described below:
The present invention by dried thin mushroom, fern fiber crops, turtle shell, thatch screwpine fruit, PORIA ALBA, ford nervilia leaf, lycium ruthenicum, henry woodbetony root, Radix Astragali, Rabdosia amethystoides, Gurgeon stopper, eclipta and hairyflower actinidia root and leaf are made.
Preferably, by weight, contain the dried thin mushroom 15%, the fern fiber crops 5%, the turtle shell 20%, the thatch screwpine fruit for every part 4%, the PORIA ALBA 4%, the ford nervilia leaf 5%, the lycium ruthenicum 5%, the henry woodbetony root 13%, the Radix Astragali 6%, the Rabdosia amethystoides 6%, the gurgeon stopper 7%, the eclipta 5%, the hairyflower actinidia root and leaf 5%.
Preparation method of the present invention the following steps are included:
(1) net turtle shell to be scalded with sand faint yellow to surface, taking-up weeds out sand, puts into vinegar liquid quench it while hot, pull out, and it is dry, Vinegar turtle shell is made；
(2) by vinegar turtle shell, dried thin mushroom, fern fiber crops, thatch screwpine fruit, PORIA ALBA, ford nervilia leaf, lycium ruthenicum, henry woodbetony root, Radix Astragali, Rabdosia amethystoides, red Nanmu, eclipta and hairyflower actinidia root and leaf weigh in proportion, are pulverized and mixed after carrying out ultraviolet sterilization, and investment blender is sufficiently mixed uniformly, Obtain premix；
(3) tabletting on tablet press machine by premix is dried 6-8 hours at 50-55 DEG C,
(4) medicinal powder after drying is put into tablet press machine carry out it is tabletted to obtain the final product.
Clinical verification:
There is whole body fatigue and weak after chemicotherapy 3 days in certain tumor patient, apathetic, perspire more, loss of appetite, appetite subtract The symptoms such as few, blood routine laboratory leukocyte, red blood cell and blood platelet decline are obvious.Above situation becomes apparent from after 7 days.Continuously take It is gradually recovered behind of the invention drug 14 days, restores normal after 21-28 days completely, the chemicotherapy in next period can be carried out, and Apparent tumor cell proliferation is not found.
Basic principles and main features and advantages of the present invention of the invention have been shown and described above.The technology of the industry Personnel are it should be appreciated that the present invention is not limited to the above embodiments, and the above embodiments and description only describe this The principle of invention, without departing from the spirit and scope of the present invention, various changes and improvements may be made to the invention, these changes Change and improvement all fall within the protetion scope of the claimed invention.The claimed scope of the invention by appended claims and its Equivalent thereof.

Claims (3)

1. a kind of treat the Chinese medicine that haemocyte declines after tumor chemoradiotherapy, it is characterised in that: by dried thin mushroom, fern fiber crops, turtle shell, big shield fishnet Son, PORIA ALBA, ford nervilia leaf, lycium ruthenicum, henry woodbetony root, Radix Astragali, Rabdosia amethystoides, gurgeon stopper, eclipta and hairyflower actinidia root and leaf are made.
2. the Chinese medicine that haemocyte declines after treatment tumor chemoradiotherapy according to claim 1, it is characterised in that: by weight Than every part containing the dried thin mushroom 15%, the fern fiber crops 5%, the turtle shell 20%, the thatch screwpine fruit 4%, the PORIA ALBA 4%, described Ford nervilia leaf 5%, the lycium ruthenicum 5%, the henry woodbetony root 13%, the Radix Astragali 6%, the Rabdosia amethystoides 6%, the gurgeon stopper 7%, the ink Non-irrigated lotus 5%, the hairyflower actinidia root and leaf 5%.
3. the Chinese medicine that haemocyte declines after treatment tumor chemoradiotherapy according to claim 1, it is characterised in that: preparation method The following steps are included:
(1) net turtle shell to be scalded with sand faint yellow to surface, taking-up weeds out sand, puts into vinegar liquid quench it while hot, pull out, and it is dry, Vinegar turtle shell is made；
(2) by vinegar turtle shell, dried thin mushroom, fern fiber crops, thatch screwpine fruit, PORIA ALBA, ford nervilia leaf, lycium ruthenicum, henry woodbetony root, Radix Astragali, Rabdosia amethystoides, red Nanmu, eclipta and hairyflower actinidia root and leaf weigh in proportion, are pulverized and mixed after carrying out ultraviolet sterilization, and investment blender is sufficiently mixed uniformly, Obtain premix；
(3) tabletting on tablet press machine by premix is dried 6-8 hours at 50-55 DEG C,
(4) medicinal powder after drying is put into tablet press machine carry out it is tabletted to obtain the final product.
CN201811484210.7A 2018-12-06 2018-12-06 It is a kind of to treat the Chinese medicine that haemocyte declines after tumor chemoradiotherapy Pending CN109331118A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201811484210.7A CN109331118A (en) 2018-12-06 2018-12-06 It is a kind of to treat the Chinese medicine that haemocyte declines after tumor chemoradiotherapy

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201811484210.7A CN109331118A (en) 2018-12-06 2018-12-06 It is a kind of to treat the Chinese medicine that haemocyte declines after tumor chemoradiotherapy

Publications (1)

Publication Number Publication Date
CN109331118A true CN109331118A (en) 2019-02-15

Family

ID=65302920

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201811484210.7A Pending CN109331118A (en) 2018-12-06 2018-12-06 It is a kind of to treat the Chinese medicine that haemocyte declines after tumor chemoradiotherapy

Country Status (1)

Country Link
CN (1) CN109331118A (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101138612A (en) * 2006-10-13 2008-03-12 北京未名宝生物科技有限公司 Antineoplastic preparations and method of preparing the same
CN104922456A (en) * 2015-06-05 2015-09-23 李京烨 Traditional Chinese medicine composition for treating anemia after tumor chemotherapy

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101138612A (en) * 2006-10-13 2008-03-12 北京未名宝生物科技有限公司 Antineoplastic preparations and method of preparing the same
CN104922456A (en) * 2015-06-05 2015-09-23 李京烨 Traditional Chinese medicine composition for treating anemia after tumor chemotherapy

Similar Documents

Publication Publication Date Title
CN104996646A (en) Health preserving tea for preventing and treating various tumors
CN101234181B (en) Medicament for preventing and treating leukopenia used in tumor radiotherapy and chemotherapy course
CN104491766B (en) One treats melanomatous Chinese medicine composition and preparation method thereof
CN103505454A (en) Alpha-tubulin inhibitor and application thereof
CN109331118A (en) It is a kind of to treat the Chinese medicine that haemocyte declines after tumor chemoradiotherapy
CN104383244B (en) It is a kind of to treat Chinese medicine composition of cancer of the esophagus and preparation method thereof
CN109745508A (en) A kind of Chinese materia medica preparation and preparation method thereof of anti-curing oncoma
CN108310173A (en) A kind of Chinese medicine preparation of auxiliary treatment early-stage cancer and its preparation method of oral solution
CN104815014A (en) Application of polygonum cuspidatum in preparation for medicine for preventing and treating ionization radiation-induced intestinal injuries
CN105169143B (en) A kind of Chinese medicine composition treating melanoma and preparation method thereof
CN104888149B (en) The drug and its preparation process for treating cervical carcinoma
CN1089000C (en) 'Sanhuangqinbao' powder-medicine for chicken
CN113769003A (en) Medicine for treating hyperplasia of mammary glands and breast tumor and preparation method thereof
CN104857393A (en) Pharmaceutical preparation for treating arrhythmia
CN110124004A (en) It is a kind of for treating the composition of medicine formula and preparation method thereof of breast cancer and breast myomata
CN112089802A (en) Traditional Chinese medicine formula for treating tumor-stage immunodeficiency and preparation method
CN107412683A (en) It is a kind of specially to control scorching medicine of chicken air bag and preparation method thereof
CN108635519A (en) A kind of composition and its processing method for treating gastric cancer
CN109692225A (en) A kind of new application of Dabaidu Capsules
CN107184912A (en) The positive disperse accumulations compound preparation of one breeding and its application
CN1421238A (en) Natural bioreaction regulator with the functions of resisting cancer, resisting free radical damage and regulating immunity
CN107929344B (en) Lithospermum compound composition for preventing and treating laryngeal cancer
CN107397860A (en) A kind of anti-tumor biological Chinese medicine preparation and processing technology
CN106237265A (en) Antitumor Chinese and preparation method thereof
Noori et al. Cytotoxic Effects of Rheum khorasanicum Extract on MCF-7 Human Breast Cancer Cell Line and ODC1 Gene Expression

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20190215